Tavneos
Tavneos Recall Summary Tavneos, a medication containing avacopan used to treat microscopic polyangiitis and Wegener granulomatosis, is being recalled across the European Union. The recall was initiated through a formal referral procedure to reassess the medicine's safety or effectiveness. This is classified as a Class II recall, meaning the product could cause adverse health effects.
- Product
- Active substances: avacopan. Therapeutic area: Microscopic Polyangiitis;Wegener Granulomatosis. ATC code: L04
- Reason
- Referral - Article 20 procedure
- Classification
- Class II
- Category
- drug recall
- Country
- European Union
- Agency
- EMA-DHPC
- Recall date
- 2026-07-16
- Status
- Ongoing
- Distribution
- European Union
Official recall notice from EMA-DHPC
Recall details on Nibble Recalls: https://trynibble.app/recalls/819068f3-edc2-48d1-bd55-7e9e141fde73